Capricor Therapeutics, Inc. (NASD:CAPR) Seasonal Chart
Seasonal analysis of Capricor Therapeutics, Inc. (NASD:CAPR) shows that a Buy Date of December 29 and a Sell Date of March 19 has resulted in a geometric average return of 33.8% above the benchmark rate.
View ArticleTempest Therapeutics Inc. (NASD:TPST) Seasonal Chart
Seasonal analysis of Tempest Therapeutics Inc. (NASD:TPST) shows that a Buy Date of December 29 and a Sell Date of March 22 has resulted in a geometric average return of 0.63% above the benchmark rate.
View ArticleRespireRx Pharmaceuticals Inc. (OTCMKT:RSPI) Seasonal Chart
Seasonal analysis of RespireRx Pharmaceuticals Inc. (OTCMKT:RSPI) shows that a Buy Date of December 30 and a Sell Date of March 22 has resulted in a geometric average return of 35.55% above the...
View ArticleAXIM Biotechnologies Inc. (OTCMKT:AXIM) Seasonal Chart
Seasonal analysis of AXIM Biotechnologies Inc. (OTCMKT:AXIM) shows that a Buy Date of December 30 and a Sell Date of May 27 has resulted in a geometric average return of 6.15% above the benchmark rate.
View ArticleMedMen Enterprises, Inc. (OTCMKT:MMNFF) Seasonal Chart
Seasonal analysis of MedMen Enterprises, Inc. (OTCMKT:MMNFF) shows that a Buy Date of December 30 and a Sell Date of March 25 has resulted in a geometric average return of 17.46% above the benchmark rate.
View ArticlePurple Biotech Ltd. (NASD:PPBT) Seasonal Chart
Seasonal analysis of Purple Biotech Ltd. (NASD:PPBT) shows that a Buy Date of December 30 and a Sell Date of March 25 has resulted in a geometric average return of 0.11% above the benchmark rate.
View ArticleAslan Pharmaceuticals Ltd (NASD:ASLN) Seasonal Chart
Seasonal analysis of Aslan Pharmaceuticals Ltd (NASD:ASLN) shows that a Buy Date of December 30 and a Sell Date of April 21 has resulted in a geometric average return of 17.87% above the benchmark rate.
View ArticleFonar Corp. (NASD:FONR) Seasonal Chart
Seasonal analysis of Fonar Corp. (NASD:FONR) shows that a Buy Date of December 30 and a Sell Date of May 24 has resulted in a geometric average return of 6.38% above the benchmark rate.
View ArticleCellectar Biosciences, Inc. (NASD:CLRB) Seasonal Chart
Seasonal analysis of Cellectar Biosciences, Inc. (NASD:CLRB) shows that a Buy Date of December 30 and a Sell Date of March 22 has resulted in a geometric average return of 0.94% above the benchmark rate.
View ArticleANI Pharmaceuticals, Inc. (NASD:ANIP) Seasonal Chart
Seasonal analysis of ANI Pharmaceuticals, Inc. (NASD:ANIP) shows that a Buy Date of December 30 and a Sell Date of April 21 has resulted in a geometric average return of 13.12% above the benchmark rate.
View Article
